Madrigal Pharmaceuticals's total assets for Q3 2025 were $1.36B, an increase of 34.18% from the previous quarter. MDGL total liabilities were $736.73M for the fiscal quarter, a 130.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.